Extendicare Inc.
EXETF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $440 | $383 | $375 | $392 |
| % Growth | 14.8% | 2.3% | -4.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $440 | $383 | $375 | $392 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $357 | $317 | $310 | $316 |
| SG&A Expenses | $357 | $317 | $310 | $316 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $43 | $35 | $38 | $44 |
| Operating Expenses | $399 | $352 | $347 | $360 |
| Operating Income | $41 | $31 | $27 | $31 |
| % Margin | 9.3% | 8.2% | 7.3% | 8% |
| Other Income/Exp. Net | -$6 | $10 | -$8 | -$4 |
| Pre-Tax Income | $34 | $41 | $19 | $27 |
| Tax Expense | $10 | $9 | $4 | $7 |
| Net Income | $24 | $32 | $15 | $20 |
| % Margin | 5.5% | 8.3% | 4% | 5.1% |
| EPS | 0.28 | 0.38 | 0.18 | 0.3 |
| % Growth | -26.3% | 111.1% | -40% | – |
| EPS Diluted | 0.28 | 0.37 | 0.18 | 0.28 |
| Weighted Avg Shares Out | 85 | 84 | 84 | 89 |
| Weighted Avg Shares Out Dil | 86 | 86 | 85 | 95 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $2 |
| Interest Expense | $5 | $4 | $5 | $6 |
| Depreciation & Amortization | $10 | $8 | $8 | $8 |
| EBITDA | $49 | $54 | $32 | $41 |
| % Margin | 11.2% | 14.2% | 8.5% | 10.5% |